Improvement of histological biopsy diagnosis of hepatocellular carcinoma by genomic biomarkers?

Gut

Volumn 60, Issue 7, 2011, Pages 881-882

  Lamerz, Rolf ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLUTAMATE AMMONIA LIGASE; GLYPICAN 3; HEAT SHOCK PROTEIN 70; TRANSCRIPTION FACTOR EZH2;

CANCER DIAGNOSIS; CANCER PATIENT; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY;

BIOPSY; CARCINOMA, HEPATOCELLULAR; EARLY DIAGNOSIS; GENOMICS; HUMANS; LIVER NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79958191491     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2011.238980     Document Type: Note

References (10)

1. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. July 2010. http://www.aasld.org/practiceguidelines/Documents/ Bookmarked%20Practice%20Guidelines/HCCUpdate2010.pdf (accessed Jul 2010).
2. International Working Party. Terminology of nodular lesions of the liver. Hepatology 1995;22:983-93.
3. International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 2009;49:658-64.
4. Llovet JM, Chen Y, Wurmbach E, et al. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology 2006;131:1758-67. (Pubitemid 46001394)
5. Ho M, Kim H. Glypican-3: a new target for cancer immunotherapy. Eur J Cancer 2011;47:333-8.
6. Chuma M, Sakamoto M, Yamazaki K, et al. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology 2003;37:198-207. (Pubitemid 36042161)
7. Christa L, Simon MT, Flinois JP, et al. Overexpression of glutamine synthetase in human primary liver cancer. Gastroenterology 1994;106:1312-20. (Pubitemid 24129249)
8. Di Tommaso L, Destro A, Seok JY, et al. The application of markers (HSP70, GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma. J Hepatol 2009;50:746-54.
9. Cai MY, Tong ZT, Zheng F, et al. EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies. Gut 2011;60:967-76.
10. Tsang DPF, Cheng ASL. Epigenetic regulation of signalling pathways in cancer: role of the histone methyltransferase EZHR. J Gastroenterol Hepatol 2011;26:19-27.